[TLX] YoY Annual Result on 31-Dec-2023 [#FY]

Stock
[TLX] Telix Pharmaceuticals Limited
Announcement Date
30-Dec-2023
Financial Year
2023
Quarter
31-Dec-2023 [#FY]
Profit Trend
YoY- 105.01%
Quarter Report
TLX's Result
TLX's Financial Summary
View:
Show?
Annual Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 496,659 160,096 7,596 5,213 3,485 195 0 -
PBT 3,087 -98,622 -99,039 -60,253 -42,815 -15,714 -6,377 -
Tax -2,124 5,457 -18,529 -15,366 -14,948 -1,884 9 -
NP 5,211 -104,079 -80,510 -44,887 -27,867 -13,830 -6,377 -
Tax Rate 68.80% - - - - - - -
Total Cost 491,448 264,175 88,106 50,100 31,352 14,025 6,377 106.22%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin 1.05 -65.01 -1,059.90 -861.06 -799.63 -7,087.06 0.00 -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS 0.02 -0.34 -0.29 -0.17 -0.12 -0.07 -0.05 -
EPS Diluted 0.02 -0.34 -0.29 -0.17 -0.12 -0.07 -0.05 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.